The US Department of Health and Human Services is requesting revisions to the labels on testosterone replacement therapies for men after reviewing new data and evidence on their safety and benefits. These updates could pave the way for easier access to testosterone replacement therapy.

FDA is removing warning labels from testosterone replacement therapy, or TRT, as a key advancement of men's health.

HHS is requesting changes to prescribing information for testosterone therapy products following a review of new clinical data and scientific evidence, according to a press…